Graphene Market Size Worth USD 2,864.1 Million by 2027, at 38% CAGR; Owing to Increasing Demand for Sustainability Solutions Globally, foresees Fortune Business Insights™
/
Date01 Sep 2020
Email Print Friendly Share Pune, Aug. 31, 2020 (GLOBE NEWSWIRE) — The global graphene market size is expected to gain momentum by reaching USD 2,864.1... Read More →
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
/
Date01 Sep 2020
Email Print Friendly Share AUCTION DATE: SEP 1, 2020 START DATE: SEP 2, 2020 MATURITY DATE: SEP 9, 2020 NOMINAL AMOUNT: 380.0 BLN FIXED RATE: 0.00 % PROJECTED... Read More →
Northland Announces Reset Dividend Rate on Its Cumulative Rate Reset Preferred Shares, Series 1 & Series 2
/
Date01 Sep 2020
Email Print Friendly Share TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland” or the “Company”) (TSX: NPI) today announced that pursuant to... Read More →
Amarillo reports second quarter results
/
Date01 Sep 2020
Email Print Friendly Share This news release should be read in conjunction with Amarillo Gold Corporation’s condensed interim consolidated financial statements and management’s discussion and... Read More →
IMCD’s growth story solidifies with the envisaged acquisition of Siyeza in South Africa
/
Date01 Sep 2020
Email Print Friendly Share ROTTERDAM, The Netherlands (1 September 2020) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today... Read More →
Air Purifiers or Air Cleaners? Camfil Expert Steve Smith Segment Manager for Air Cleaners and Purifiers Explains
/
Date01 Sep 2020
Email Print Friendly Share Camfil’s Steve Smith, Segment Manager for Air Cleaners and Purifiers, In a new video (Air Cleaner & Air Purifier Applications What... Read More →
Doggykingdom Is Proud to Celebrate it's 500,000th Sale
/
Date01 Sep 2020
Email Print Friendly Share New York, New York, Sept. 01, 2020 (GLOBE NEWSWIRE) — Doggykingdom is proud to celebrate the sale of over 500,000 dog... Read More →
Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH
/
Date01 Sep 2020
Email Print Friendly Share First investigational trial of a drug-biologic bone graft for spine fusion Phase 2 trial in the U.S. compares Fibrin-PTH (KUR-113) with... Read More →